The traditional approach to creating ventilation masks has often been a cumbersome process, involving the use of generic equipment that may not fit optimally for every child, particularly those in critical condition. This inadequacy can lead to discomfort and inefficient ventilation, ultimately compromising respiratory support. The study led by Pigmans et al. investigates the viability of utilizing facial 3D data acquisition techniques to fabricate custom-fit masks that align closely with the individual facial features of young patients. This personalization is not just a matter of comfort; it has the potential to substantially improve the efficacy of respiratory treatments.

One of the most significant components of this study is the methodology employed in capturing 3D facial data. Researchers used state-of-the-art 3D scanning technology that renders intricate details of a child’s face, allowing for precise measurements and a tailored fit. This non-invasive method provided a quick and efficient alternative to traditional casting techniques, which are often uncomfortable and impractical in critical situations. The rapid acquisition of 3D data supports the idea of swiftly crafting masks that can be produced on-demand, thereby addressing urgent medical needs with unprecedented efficiency.

The implications of such innovations extend beyond mere comfort. The study presents early evidence suggesting that personalized masks could lead to improvements in ventilation efficacy and patient outcomes. With the ability to create a well-fitted mask, the risk of leaks—one of the major issues in non-invasive ventilation—could be significantly reduced. Fewer leaks mean that the necessary positive pressure can be more reliably maintained, optimizing respiratory therapy for critically ill children, many of whom may be suffering from conditions requiring immediate and ongoing respiratory support.

Challenges encountered during the initial phases of this project reflect the complexities of conducting research in sensitive environments, particularly with young patients. Ethical considerations took center stage, guiding the researchers in obtaining consent from guardians while ensuring that the child’s wellbeing remained paramount. Stepping into the unknown, Pigmans et al. navigated these hurdles with care, determined to pioneer a path that could redefine pediatric care protocols in the future.

As this research unfolds, collaboration with pediatricians, respiratory therapists, and engineers will be critical. Building cross-disciplinary teams fosters an environment where ideas flourish, and innovations stem from varied expertise. The study hints at the importance of such partnerships, underscoring that the blend of clinical insight with technological advancement could yield groundbreaking solutions tailored to the needs of some of the most vulnerable patients.

The advent of 3D printing technology has already made significant waves in the medical field; however, the application of 3D data acquisition for bespoke ventilation masks represents a crucial next step in this evolution. This feasibility study acts as a proof of concept that demonstrates not only the technical capability but also the potential for implementation into standard clinical practice. If adopted widely, this approach could serve as a blueprint for developing other forms of personalized medical devices, offering a future where patient-centric care is the norm rather than the exception.

Importantly, the authors of this study are careful to frame their findings within the context of ongoing work and future steps. As they move forward, a focus on larger trials to validate these initial findings will be vital. Scaling up the research will involve examining the long-term effects of personalized ventilation masks on patient outcomes, as well as exploring the economic implications of such technology. Will the benefits justify the costs associated with implementing these personalized solutions in clinical settings? Only careful evaluation and continued innovation will provide answers to these pressing questions.

Furthermore, as the medical community continues to grapple with the realities of treating critically ill children, insights gained from this research could help shape broader standards of care. Standard protocols for intubation and ventilation can always benefit from updated practices that prioritize individualization based on real-world data rather than broad assumptions. The goal is a healthcare landscape where technology aligns harmoniously with patient needs, resulting in better care experiences and outcomes.

The potential for widespread application of this technology raises another crucial question: How can other healthcare systems and organizations across different sectors learn from this study? Education and dissemination of knowledge will be key factors in fostering an environment where such innovations are embraced. By sharing findings at conferences and through publications, Pigmans et al. can inspire other researchers to explore similar pathways in their specialties, fostering an ecosystem of continuous improvement in patient care.

As the journey of personalized non-invasive ventilation masks continues, there’s no doubt that the integration of cutting-edge technologies into clinical practice offers a hopeful prospect for the future of healthcare. This feasibility study serves not only as a confirmation of concept but as a beacon of potential, illuminating the road ahead for innovative healthcare solutions that place pediatric patients at the forefront.

In conclusion, the bridged path between technology and medical care illustrated by this research could lead to great things within the realm of pediatric healthcare, achieving the vital goal of enhancing patient comfort, safety, and outcomes. The implications of personalized non-invasive ventilation masks could set a new benchmark in respiratory therapy, paving the way for further breakthroughs and innovative practices that ensure critically ill children receive the specialized care they urgently need.

Subject of Research: Personalized non-invasive ventilation masks for critically ill children using 3D data acquisition.

Article Title: Facial 3D data acquisition in critically ill children for production of personalized non-invasive ventilation masks: a feasibility study.

Article References:

Pigmans, R.R.W.P., Goto, L., Wientjes, R. et al. Facial 3D data acquisition in critically ill children for production of personalized non-invasive ventilation masks: a feasibility study.
3D Print Med 12, 2 (2026). https://doi.org/10.1186/s41205-025-00311-9

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s41205-025-00311-9

Keywords: Pediatric care, non-invasive ventilation, 3D data acquisition, personalized medicine, respiratory therapy.

One of the primary findings of the research is the multifaceted nature of medical complexity among children, which can encompass a range of chronic conditions, disabilities, and specialized healthcare needs. These factors complicate the discharge process as they necessitate a tailored approach to planning and preparation. Unlike children with less complicated medical backgrounds, those with significant health challenges often require a more comprehensive support system to ensure continuity of care once they leave the hospital environment. Efforts to streamline this transition can greatly impact both the child’s recovery and family dynamics.

The research underscores the importance of a collaborative approach in discharge planning. Involving a multidisciplinary team, which may include physicians, nurses, social workers, and therapists, allows for a more holistic assessment of the child’s needs. Such collaboration fosters a more comprehensive understanding of potential barriers families may face after discharge. By addressing these concerns proactively, healthcare providers can help to facilitate a smoother transition and enhance the overall effectiveness of post-discharge care.

Communication emerges as a pivotal element in supporting discharge preparation for children with medical complexity. Families often feel overwhelmed by the information presented to them during the discharge process, and it is crucial that healthcare providers deliver this information in an accessible and understandable manner. The research highlights the necessity for educational materials that are tailored to the family’s level of understanding, which can empower parents and caregivers with the knowledge they need to manage their child’s care effectively once they are home.

Additionally, the study identifies the emotional toll that the discharge process can take on families. Parents of children with medical complexities frequently experience anxiety and uncertainty about their ability to care for their child outside of a clinical environment. Addressing these emotional needs is just as important as meeting the medical requirements of the child. Interventions focused on mental health support for families should be integrated into discharge planning to promote resilience and confidence among parents and caregivers.

The complexity of follow-up care is another critical aspect highlighted in the scoping review. Children with complex medical conditions often require ongoing appointments with various specialists, which can be daunting for families to coordinate. The review calls for systems that streamline scheduling and provide families with clear guidelines on the necessary follow-up care. Simplifying these processes can alleviate some of the burdens placed on families and ensure that children receive the timely care they need to thrive after leaving the hospital.

Moreover, the review emphasizes the role of technology in enhancing discharge preparation. Telehealth services have seen a surge in adoption, providing a valuable resource for families as they transition to home care. Virtual consultations can offer ongoing support and guidance, making it easier for families to connect with healthcare providers and obtain answers to their questions. The use of mobile applications and digital tools can also empower families by equipping them with resources to track their child’s symptoms, medication schedules, and appointments, ultimately improving adherence to treatment plans.

In addition to addressing physical health needs, the review highlights the importance of considering social determinants of health when planning for discharge. Factors such as access to transportation, availability of community resources, and financial stability can significantly impact a family’s ability to manage care at home. Healthcare providers must take these elements into account and work to connect families with support services that can mitigate barriers to care, fostering a more sustainable approach to managing their child’s health.

The implications of this scoping review extend beyond the individual families of children with medical complexities. Policymakers and healthcare institutions stand to benefit by implementing the findings to enhance discharge planning protocols. By integrating evidence-based best practices into hospital discharge processes, hospitals can improve patient outcomes, reduce readmission rates, and better serve the needs of the community. Establishing programs that focus on pre-discharge education and follow-up support can create a more proactive healthcare environment that prioritizes the well-being of families.

In conclusion, the scoping review by Moore, Waldron, Acorda, and colleagues is a groundbreaking contribution to the literature on pediatric discharge preparation. By emphasizing the importance of a collaborative, communicative, and holistic approach, this research paves the way for improved care strategies that can significantly benefit children with medical complexities and their families. As the landscape of healthcare continues to evolve, adopting such strategies will be key to enhancing patient experiences and outcomes in the discharge process.

As healthcare providers and institutions reflect on the findings of this important review, it is essential to foster an environment of innovation and continuous improvement. The path toward effectively supporting families at the intersection of hospital and home care is fraught with challenges, but with a commitment to understanding and addressing the unique needs of children with medical complexities, there is potential for profound positive change. Implementing these insights not only holds the promise of better health outcomes but also champions the rights of families to receive comprehensive and compassionate care throughout their healthcare journey.

Subject of Research: Discharge preparation for children with medical complexity

Article Title: Supporting discharge preparation for children with medical complexity: a scoping review

Article References:

Moore, E., Waldron, M., Acorda, D. et al. Supporting discharge preparation for children with medical complexity: a scoping review.
BMC Nurs 24, 1284 (2025). https://doi.org/10.1186/s12912-025-03904-1

Image Credits: AI Generated

DOI: 10.1186/s12912-025-03904-1

Keywords: discharge planning, pediatric care, medical complexity, healthcare communication, family support, telehealth, social determinants of health

Congenital chest lesions can manifest in a variety of forms, leading to confusion among healthcare providers, parents, and patients. This confusion is often likened to an “alphabet soup,” where the myriad of acronyms and terminologies can overwhelm those who attempt to navigate this complex landscape. In their work, Boggs and Kucera aim to demystify the various types of chest lesions, organizing them into a cohesive system that enhances understanding and facilitates better communication across medical disciplines.

Pediatric radiologists play a crucial role in the detection and management of congenital chest lesions. Accurate imaging techniques are pivotal for identifying and characterizing these anomalies. The authors underscore the importance of advanced imaging modalities, such as computed tomography and magnetic resonance imaging, which have revolutionized our ability to visualize and diagnose these congenital conditions. By employing these tools, radiologists can assess chest lesions with unprecedented precision, laying the groundwork for effective treatment planning.

The systematic approach proposed by the authors categorizes congenital chest lesions into several distinct groups based on their anatomical and developmental characteristics. This classification system empowers healthcare professionals to better identify and manage these lesions, ultimately leading to improved patient outcomes. By breaking down the complexities of congenital anomalies into readily understandable categories, the authors provide a framework that is both functional and accessible.

Moreover, the implications of this research extend beyond diagnostics; they also touch on the need for standardized protocols in the management of congenital chest lesions. As these anomalies can vary significantly in presentation and severity, a clear set of guidelines can aid clinicians in tailoring treatment plans that address the individual needs of each patient. The authors advocate for a collaborative approach among specialists, including pediatric surgeons and radiologists, to ensure that all facets of patient care are considered.

The exploration of genetic factors associated with congenital chest lesions is another pivotal aspect of this research. Recent advancements in genetic testing and genomics have opened new avenues for understanding the etiology of these conditions. By identifying specific genetic markers, clinicians can gain insights into the likely manifestations and potential complications associated with particular congenital chest lesions. This information is invaluable for risk assessment and family counseling, as it elucidates the underlying causes of these anomalies.

In addition to the medical ramifications, the psychological aspects of congenital chest lesions cannot be overlooked. Families grappling with a diagnosis often face emotional turmoil as they navigate the complexities of treatment options and potential outcomes. The authors highlight the importance of providing comprehensive support to patients and their families throughout the diagnostic and treatment processes. This holistic approach acknowledges the significant role that emotional well-being plays in overall health.

Public awareness and education about congenital chest lesions is imperative for early detection and intervention. The proliferation of online platforms and social media can serve as powerful tools for disseminating information to parents and caregivers. By fostering awareness of the signs and symptoms of these congenital conditions, healthcare providers can empower families to seek medical assistance promptly, which can be a decisive factor in improving prognoses.

As this research gains traction, it opens the door for further studies aimed at refining the understanding of congenital chest lesions. The authors call for additional investigations that explore the long-term outcomes of patients with these anomalies, including those who undergo surgical interventions. The pursuit of this knowledge is essential for developing evidence-based guidelines that support optimal care.

Looking ahead, the systematic approach proposed by Boggs and Kucera carries the potential to influence not only clinical practices but also the educational curricula for medical professionals. Incorporating clear classifications and management strategies into training programs can prepare the next generation of healthcare providers to face the challenges of congenital chest lesions. This proactive stance is indispensable for fostering a generation of practitioners who are equipped with the knowledge and skills to navigate this complex field.

In conclusion, “Alphabet soup: a systematic approach to understanding congenital chest lesions” serves as a significant contribution to the pediatric medical literature. By unpacking the complexities associated with congenital chest lesions, Boggs and Kucera offer a comprehensive framework that enhances understanding, informs clinical practice, and ultimately improves patient care. As the medical community continues to engage with this vital area of research, the potential for improved outcomes for children and their families expands exponentially.

Through this work, there is a renewed hope for those affected by congenital chest lesions—a hope that stems not only from medical advances but also from a collective commitment to understanding and addressing the unique challenges posed by these conditions.

Subject of Research: Understanding congenital chest lesions

Article Title: Alphabet soup: a systematic approach to understanding congenital chest lesions

Article References:

Boggs, Z., Kucera, J. Alphabet soup: a systematic approach to understanding congenital chest lesions.
Pediatr Radiol (2025). https://doi.org/10.1007/s00247-025-06392-2

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s00247-025-06392-2

Keywords: congenital chest lesions, pediatric radiology, imaging techniques, genetic factors, treatment protocols, patient support, awareness, education.

Neuromuscular disorders encompass a heterogeneous group of conditions characterized by impaired function of muscles and the nerves that control them. These conditions often manifest early in childhood, leading to progressive muscle weakness, disability, and, in severe cases, life-threatening complications. The diversity of clinical presentations combined with the overlapping symptoms shared among different disorders traditionally complicates the diagnostic odyssey—rarely straightforward and frequently prolonged with numerous tests and inconclusive findings.

In traditional diagnostics, clinical evaluations and muscle biopsies constitute the mainstay methods. However, their efficacy is limited by sample accessibility, the invasiveness of procedures, and the inability to reveal the precise molecular etiology in many cases. Additionally, single-gene testing approaches are often narrow in scope, hindering comprehensive analysis. This is where next-generation sequencing emerges as a transformative tool. Leveraging massively parallel sequencing, NGS facilitates a broad, unbiased scan of multiple genes simultaneously, thus offering an opportunity to detect pathogenic variants responsible for neuromuscular disorders.

The study highlights the application of targeted gene panels and whole-exome sequencing in a cohort of pediatric patients whose neuromuscular conditions remained enigmatic after exhaustive standard workups. By utilizing NGS, the researchers successfully identified disease-causing mutations in a significant subset of previously undiagnosed cases, elucidating new genetic correlations and expanding the phenotypic spectrum associated with characterized genes. This not only underscores the sensitivity of NGS but also its capacity to illuminate novel genotype-phenotype relationships essential for precise diagnosis.

Crucially, the authors emphasize the integration of bioinformatics pipelines tailored to neuromuscular disease gene sets, optimizing variant interpretation and prioritizing clinically meaningful mutations. The workflow employed in their analysis incorporates stringent filtering strategies to distinguish pathogenic variants from benign polymorphisms, with a combination of in silico prediction tools, population frequency data, and functional annotation. Such meticulous curation is vital to mitigate false positives, a known challenge inherent in large-scale sequencing data.

Moreover, the research delineates how early genetic diagnosis via NGS can profoundly impact patient management, enabling timely interventions, informing prognosis, guiding genetic counseling, and facilitating enrollment in emerging clinical trials tailored to specific molecular defects. This precision medicine approach contrasts sharply with the generalized treatment paradigms that often prevail when diagnosis remains uncertain, thereby underlining the clinical utility and transformative potential of genomic technologies.

While next-generation sequencing shines as a beacon of hope, the study also acknowledges inherent challenges—chief among them the interpretation of variants of uncertain significance (VUS) and incidental findings unrelated to the primary neuromuscular disorder. The authors call for continuous refinement of variant databases and interdisciplinary collaboration between clinicians, geneticists, and bioinformaticians to refine interpretive frameworks, thereby enhancing diagnostic yield and clinical relevance.

The cost-effectiveness of incorporating NGS into routine diagnostics also garners attention within the study. Although upfront expenses may be considerable, the cumulative benefits derived from accelerated diagnosis, avoidance of redundant testing, and personalized treatment strategies can offset initial investments, particularly in healthcare systems committed to long-term patient outcomes and resource optimization.

Importantly, the paper sheds light on the ethical considerations surrounding pediatric genetic testing. Issues such as informed consent, data privacy, and potential psychosocial impacts on families necessitate thoughtful navigation. The authors advocate for comprehensive genetic counseling services integrated within the diagnostic process to support families as they assimilate complex genetic information and make consequential healthcare decisions.

On the technological front, the study also explores the future frontier of NGS applications, envisaging integration with transcriptomics and proteomics to construct multi-omics profiles. Such holistic approaches promise even deeper insights into disease mechanisms, potentially unveiling novel therapeutic targets and fostering the development of personalized medicine tailored to each child’s unique genetic landscape.

Overall, this research embodies a paradigm shift in pediatric neuromuscular diagnostics. The compelling evidence presented toward the efficacy of next-generation sequencing, combined with its multifaceted benefits, heralds a new era where elusive diagnostic questions give way to clarity, and affected children receive care informed by the precise genetic underpinnings of their conditions. The study fortifies the argument that NGS should transition from experimental consideration to a frontline tool in pediatric neurology.

In conclusion, Kulsirichawaroj and colleagues have successfully demonstrated that next-generation sequencing acts as a critical key in unlocking the mysteries of unresolved pediatric-onset neuromuscular disorders. Their work not only pushes the boundaries of genetic diagnostics but also fuels optimism for enhanced patient outcomes through genomic medicine. The fusion of innovative sequencing technologies with clinical acumen stands poised to redefine standards of care, empowering clinicians and families alike with knowledge and hope.

This scientific breakthrough beckons a future where no child’s condition remains undiagnosed due to limitations of traditional methods. As NGS platforms become more accessible and integrated into healthcare workflows worldwide, an era of precision diagnostics for neuromuscular disorders in children is dawning—one marked by rapid discoveries, tailored therapies, and improved quality of life.

As the medical community continues to refine these tools and cultivate expertise in genomic medicine, the ripple effects of this study will undoubtedly amplify, inspiring further research and clinical applications. The intersection of advanced genomics and pediatric neurology promises to unravel pathologies once hidden in the shadows, finally bringing the light of understanding to families and clinicians navigating the complexities of neuromuscular disease.

Subject of Research: Next-generation sequencing application in pediatric-onset neuromuscular disorders unresolved by traditional diagnostics.

Article Title: Next-generation sequencing for pediatric-onset neuromuscular disorders unresolved by conventional diagnostic methods.

Article References:
Kulsirichawaroj, P., Chanvanichtrakool, M., Wattanadilokchatkun, P. et al. Next-generation sequencing for pediatric-onset neuromuscular disorders unresolved by conventional diagnostic methods. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04160-4

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-025-04160-4

Acute respiratory infections remain a leading cause of morbidity in pediatric populations worldwide, with RSV, ADV, hPIV, and MP accounting for a substantial proportion of hospitalizations, complications, and healthcare burden. Traditional diagnostic approaches often rely on multiple, time-consuming molecular tests or culture methods that delay therapeutic decisions. The PCR-MT assay harnesses microfluidic platforms to miniaturize and automate nucleic acid amplification processes, reducing hands-on time and minimizing contamination risks while enhancing sensitivity and specificity.

The researchers set out to rigorously evaluate the diagnostic performance of the PCR-MT system in a clinical setting, enrolling a pediatric cohort presenting with respiratory symptoms indicative of ARIs. The assay’s design allows simultaneous multiplexed detection of viral and bacterial nucleic acids from a single clinical specimen, such as nasopharyngeal swabs, streamlining workflow in busy hospital laboratories. By automating every step from sample preparation through amplification and signal detection, the platform significantly reduces the turnaround time to results compared to conventional methods.

At the heart of this technology is the integration of microfluidics, a field focusing on the precise control and manipulation of fluids at the microliter scale. This miniaturization of laboratory processes onto “lab-on-a-chip” devices allows for concurrent reactions to be performed with minimal reagent volumes, faster thermal cycling, and improved assay kinetics. The fluorescence-based detection component leverages real-time monitoring of amplified nucleic acids using target-specific probes, enabling quantification and verification of pathogen presence with high accuracy.

In the study, the PCR-MT assay demonstrated remarkable sensitivity and specificity across all four targeted pathogens. Its ability to detect and distinguish between viral and atypical bacterial agents without cross-reactivity was a critical finding, underscoring the robustness of probe design and reaction optimization. Furthermore, the assay maintained consistent performance even when challenged with varying viral loads typical of clinical specimens, highlighting its utility across diverse stages of infection.

An important advantage of the fully automated system is its minimal requirement for specialized laboratory expertise. By consolidating complex molecular diagnostics into a user-friendly platform, it broadens the accessibility of advanced testing to smaller or resource-limited healthcare settings, where rapid and reliable pathogen identification is often challenging. This democratization of molecular diagnostics holds promise for improving early intervention, infection control, and antimicrobial stewardship.

Beyond its clinical utility, this assay offers the potential for epidemiological surveillance by providing timely data on circulating respiratory pathogens in pediatric populations. Rapid identification of prevalent strains can inform vaccination strategies, outbreak response, and public health policymaking. The compact and automated nature of the PCR-MT platform supports deployment in decentralized locations, enhancing real-time monitoring capabilities during peak respiratory illness seasons.

The implications of this technological advancement extend to therapeutic decision-making as well. Accurate differentiation between viral and bacterial etiologies of ARIs can significantly influence antibiotic usage, reducing unnecessary prescriptions that contribute to antimicrobial resistance. With instant access to precise pathogen profiles, clinicians can tailor treatment regimens more effectively, improving patient outcomes and curtailing healthcare costs.

While the study emphasizes the promising diagnostic accuracy and operational efficiency of the PCR-MT system, further investigations assessing its performance in larger, multicenter cohorts will be essential to validate and standardize its clinical deployment. Additional research into expanding the pathogen panel and integrating resistance gene detection may further enhance its value in comprehensive respiratory infection diagnostics.

In an era where respiratory infections remain a significant global health challenge, particularly among vulnerable pediatric populations, innovations like the automatic real-time fluorescence PCR combined with microfluidic technology represent a convergence of molecular biology, engineering, and clinical medicine. This integration not only accelerates diagnosis but also supports precision medicine approaches tailored to individual patient needs.

As emerging respiratory pathogens continue to pose diagnostic challenges, adaptable platforms such as PCR-MT could provide a versatile framework for rapid assay development and deployment. The modular nature of microfluidic chips enables swift incorporation of new target assays in response to epidemics or pandemics, positioning this technology at the forefront of future infectious disease preparedness.

In conclusion, the study conducted in Zhejiang underscores the feasibility and efficacy of a fully automatic nucleic acid amplification system utilizing microfluidic real-time PCR for the rapid and accurate detection of four key pediatric respiratory pathogens. This innovation presents a paradigm shift in balancing speed, accuracy, and operational simplicity in clinical diagnostics and has the potential to significantly impact patient care and public health initiatives.

The advancement holds promise not only in enhancing diagnostic workflows but also in shaping the broader landscape of respiratory infection management. By bridging cutting-edge technology with clinical application, it paves the way for improved health outcomes in children facing the burden of acute respiratory infections across healthcare systems worldwide.

This research heralds a new chapter in respiratory pathogen detection, where speed does not compromise precision and complexity is elegantly managed through automation. As the healthcare community continues to grapple with the challenges posed by respiratory illnesses, such innovations are critical for advancing diagnostic capabilities and fostering a responsive, informed clinical environment dedicated to pediatric health.

Subject of Research: Evaluation of a fully automatic nucleic acid amplification system for detecting Respiratory syncytial virus (RSV), adenovirus (ADV), human parainfluenza virus (hPIV), and Mycoplasma pneumoniae (MP) in children with acute respiratory infections.

Article Title: Evaluation of a fully automatic nucleic acid amplification system for detecting four respiratory pathogens.

Article References:
Chen, Yy., Xiang, Wq., Guo, Yj. et al. Evaluation of a fully automatic nucleic acid amplification system for detecting four respiratory pathogens. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04101-1

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-025-04101-1